GLYNDA DARADAR: Open Payments
NPI 1366913626 · HAZLET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 19 payments from 10 companies in 2025. Trend: 2023 $308 · 2024 $805 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $121 |
| Merck Sharp & Dohme LLC | 4 | $71 |
| Boston Scientific Corporation | 2 | $57 |
| PFIZER INC. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| CVRx, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| BridgeBio Pharma, Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
Products named: SAPIEN 3 Ultra RESILIA, VERQUVO, BodyGuardian, VYNDAQEL, CAMZYOS, Barostim Neo System, JARDIANCE, Attruby.
Industry payments across NJ — which companies pay providers there.
